Non-surgical method for the induction of delayed implantation and recovery of viable blastocysts in rats and mice by the use of tamoxifen and Depo-Provera

Molecular Reproduction and Development

Volumn 52, Issue 1, 1999, Pages 29-32

  Hunter, Susan Maclean ^a   Evans, Martin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Agonist; Antagonist; Anti oestrogen; Blastocyst; ES cells; Implantational delay

Indexed keywords

MEDROXYPROGESTERONE ACETATE; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLASTOCYST; DRUG HALF LIFE; EMBRYO INDUCTION; HORMONE ACTION; MOUSE; NIDATION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PSEUDOPREGNANCY; RAT;

EID: 0032889952     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(199901)52:1<29::AID-MRD4>3.0.CO;2-2     Document Type: Article

References (19)

1. Aitken RJ. 1978. The hormonal control of implantation. Ciba Found Symp 64:53-83.
2. Carl ton MBL, Colledge WH, Evans MJ. 1995. Generation of a pseudogene during retroviral infection. Mammalian Genome, 6:90-95.
3. Dickman Z. 1973. Postcoital contraceptive effects of medroxyprogesterone acetate and oestrone in rats. J Reprod-Fertil 32:65-69.
4. Dix CJ, Jordan VC. 1980. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen. Endocrinology 107:2011-2020.
5. Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
6. Fuentealba B, Nieto M, Croxatto HB. 1988. Progesterone abbreviates the nuclear retention of estrogen receptor in the rat oviduct and counteracts estrogen action on egg transport. Biol Reprod. 38:63-69.
7. Gronemeyer II, Benhamou B, Berry M, Bocquel MT, Gofilo D, Garcia T, et al. 1992. Mechanisms of antihormone action. J Steroid Biochem Mol Biol 41:217-221.
8. Harper MJK, Walpole AL. 1967a. Mode of action of I.C.I. 46,474 in preventing implantation in rats. J Endocrinol 37:83-92.
9. Harper MJK, Walpole AL. 1967b. A new derivative of triphenylethylene: effect on implantation and mode of action in rats. J Reprod Fertil 13:101-119.
10. Jordan VC, Gosden B. 1983. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018. Endocrinology 113:463-468.
11. Kaplan-Kraicer R, Kostovetsky I, Bardin CW, Shalgi R. 1996. Tamoxifen and RU39411 synergize with mifepristone to produce preimplantation pregnancy loss by increasing embryo transport (rat). Contraception 53:367-373.
12. Kuehn MR, Bradley A, Robertson EJ, Evans MJ. 1987: A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326:295-298.
13. McLaren A. 1973. Blastocyst activation. In: Segal SJ, et al., Editors. The regulation of mammalian reproduction. Springfield, IL: Thomas, p 321-334.
14. Quinn P, Barros C, Whittingham DG. 1982. Preservation of hamster oocytes to assay the fertilizing capacity of human spermatozoa. J Reprod Fertil 66:161-168.
15. Trams G, Brewitt H, Mollmann H, Maass H. 1973. Effect of progesterone on RNA and protein synthesis in the rat uterus. Acta Endocrinol Copen 73:740-750.
16. Weitlauf HM. 1971. Effect of progesterone on survival of blastocysts in uteri of ovariectomized mice. J Endocrinol 51:375-380.
17. Weitlauf HM. 1974. Metabolic changes in the blastocysts of mice and rats during delayed implantation. J Reprod Fertil 39:213-224.
18. Weitlauf HM, Greenwald GS. 1968. Survival of blastocysts in the uteri of ovariectomized mice. J Reprod Fertil 17:515-520.
19. Yoshinaga K. 1974. Ovarian progestin secretion in lactating rats: effect of intrabursal injection of prolactin antiserum, prolactin and LH. Endocrinology 94:829-834.